Views & Analysis | Perspectives on pharma industry issues

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.

Market Access

Biotech's next growth cycle: Renewed confidence comes with c...

Renewed confidence across biopharma is welcome and long overdue after a prolonged period of constraint. But confidence alone is not enough.

Oncology

The future of oncology is adaptive: What ESMO 2026 revealed ...

Across tumours, three developments repeatedly surfaced throughout the congress, each reflecting a notable transition in how cancer is being managed.

Market Access

Sponsored

Solution Spotlight: Acumetis Model Builder

Acumetis Model Builder is a web-based platform that generates complete, formula-linked Excel cost-effectiveness and budget impact models in minutes.

Articles

Key challenges within rare disease clinical trials

Yaffa Rubinstein shares the goals of the Office of Rare Diseases Research and explains some of the key challenges the rare disease patient community faces when it comes to recruiting for clinical trials. One of the biggest challenges in clinical trials is patient recruitment for rare diseases. But with the rise in public awareness...

Articles

Open access innovating in clinical trial reporting

Angela Wipperman, Helene Faure and Iain Hrynaszkiewicz share their opinions on open access innovation when reporting about clinical trials. Online, open access medical publishing has provided new opportunities for increased transparency and innovation in clinical trial reporting...

Articles

Should pharma continue to invest in disease state education ...

Richard Meyer explains why it is time we started looking at pharmaceutical marketing through the eyes of the consumer. One of the greatest strengths any marketer can demonstrate is the ability to look at their marketing as a consumer not a DTC marketer...

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.

Digital